* Generation Bio Co is expected to show a fall in quarterly revenue when it reports results on November 7 (estimated) for the period ending September 30 2024

* The Cambridge Massachusetts-based company is expected to report a 12.3% decrease in revenue to $1.882 million from $2.15 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

* ​LSEG's mean analyst estimate for Generation Bio Co is for a loss of 28 cents per share.

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

* The mean earnings estimate of analysts was unchanged in the last three months. ​

* Wall Street's median 12-month price target for Generation Bio Co is $7.50​, above​ its last closing price of $2.19. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI

ENDING ARTESTIMAT ESTIMATE MET, SE %

E® MISSED

Jun. 30 2024 -0.29 -0.28 -0.31 Missed -11.3

Mar. 31 2024 -0.40 -0.41 -1.12 Missed -174.4

Jan. 1 0001 -0.44 -0.45 -0.53 Missed -18.2​

Jan. 1 0001 -0.50 -0.50 -0.43 Beat 14.9

​​Jan. -0.50 -0.50 -0.47 Beat 5.4

1 0001

Mar. 31 2023 -0.45 -0.46 -0.53 Missed -14.2​

Dec. 31 2022 -0.58 -0.58 -0.55 Beat 5

Sep. 30 2022 -0.66 -0.67 -0.53 Beat 21.1

This summary was machine generated November 6 at 04:58 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)